Brain, Vol. 107, No. 1, 253-274, 1984
© 1984 Oxford University Press
research-article |
NEURAL INPUTS INTO THE NUCLEUS BASALIS OF THE SUBSTANTIA INNOMINATA (Ch4) IN THE RHESUS MONKEY
From the Bullard and Denny-Brown Laboratories, the Behavioral Neurology Section of the Harvard Neurology Department and the Charles A. Dana Research Institute of the Beth Israel Hospital Boston, MA 02215, USA
Correspondence to:
Correspondence to: Dr M. Mesulam, Neurological Unit, Beth Israel Hospital, 330 Brookline Avenue, Boston, MA 02215 USA.
Neurons of the nucleus basalis-substantia innominata-nucleus of the ansa peduncularis complex (Ch4) provide the major source of cholinergic innervation for the entire neocortical surface. In contrast to their widespread projections to all parts of the neocortex, these neurons receive reciprocal projections from only very few cortical areas. Most of the sensory, motor, and association areas in the frontal, parietal, occipital and temporal lobes do not seem to project back to the Ch4 complex. The Ch4 neurons receive their cortical input from prepyriform cortex, orbitofrontal cortex, the anterior insula, the temporal pole, entorhinal cortex and the medial temporal cortex. There are also subcortical inputs from septal nuclei, the nucleus accumbens-ventral pallidum complex and the hypothalamus. This organization suggests that the Ch4 complex is in a position to act as a cholinergic relay for transmitting predominantly limbic and paralimbic information to the neocortical surface. It would also appear that the cortical areas which do not project into Ch4 have no direct way of controlling the cholinergic input which they receive, whereas the limited set of cortical areas which do project into Ch4 can control not only the cholinergic innervation that they receive but also the cholinergic innervation into the entire neocortical mantle.
Received April 26, 1983.
Revised July 14, 1983.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. J. Englot, B. Modi, A. M. Mishra, M. DeSalvo, F. Hyder, and H. Blumenfeld Cortical Deactivation Induced by Subcortical Network Dysfunction in Limbic Seizures J. Neurosci., October 14, 2009; 29(41): 13006 - 13018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tangwongchai, N. Thavichachart, V. Senanarong, N. Poungvarin, K. Phanthumchinda, R. Praditsuwan, S. Nidhinandana, and S. Chankrachang Galantamine for the Treatment of BPSD in Thai Patients With Possible Alzheimer's Disease With or Without Cerebrovascular Disease American Journal of Alzheimer's Disease and Other Dementias, January 1, 2009; 23(6): 593 - 601. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Robbins and A. Roberts Differential Regulation of Fronto-Executive Function by the Monoamines and Acetylcholine Cereb Cortex, September 1, 2007; 17(suppl_1): i151 - i160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Protopopescu, H. Pan, M. Altemus, O. Tuescher, M. Polanecsky, B. McEwen, D. Silbersweig, and E. Stern Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle PNAS, November 1, 2005; 102(44): 16060 - 16065. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mesulam The Cholinergic Lesion of Alzheimer's Disease: Pivotal Factor or Side Show? Learn. Mem., January 1, 2004; 11(1): 43 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gaffan, A. Easton, and A. Parker Interaction of Inferior Temporal Cortex with Frontal Cortex and Basal Forebrain: Double Dissociation in Strategy Implementation and Associative Learning J. Neurosci., August 15, 2002; 22(16): 7288 - 7296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Easton, R.M. Ridley, H.F. Baker, and D. Gaffan Unilateral Lesions of the Cholinergic Basal Forebrain and Fornix in One Hemisphere and Inferior Temporal Cortex in the Opposite Hemisphere Produce Severe Learning Impairments in Rhesus Monkeys Cereb Cortex, July 1, 2002; 12(7): 729 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ohnishi, H. Matsuda, T. Tabira, T. Asada, and M. Uno Changes in Brain Morphology in Alzheimer Disease and Normal Aging: Is Alzheimer Disease an Exaggerated Aging Process? AJNR Am. J. Neuroradiol., October 1, 2001; 22(9): 1680 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ohnishi, H. Matsuda, T. Hashimoto, T. Kunihiro, M. Nishikawa, T. Uema, and M. Sasaki Abnormal regional cerebral blood flow in childhood autism Brain, September 1, 2000; 123(9): 1838 - 1844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Van Hoesen, J. Parvizi, and C.-C. Chu Orbitofrontal Cortex Pathology in Alzheimer's Disease Cereb Cortex, March 1, 2000; 10(3): 243 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Cummings Cholinesterase Inhibitors: A New Class of Psychotropic Compounds Am J Psychiatry, January 1, 2000; 157(1): 4 - 15. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. E. Arnold, B. T. Hyman, and G. W. Van Hoesen Neuropathologic Changes of the Temporal Pole in Alzheimer's Disease and Pick's Disease Arch Neurol, February 1, 1994; 51(2): 145 - 150. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Mesulam Asymmetry of neural feedback in the organization of behavioral states Science, July 31, 1987; 237(4814): 537 - 538. [PDF]
|
|